Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cytomx Thera (CTMX)

Cytomx Thera (CTMX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cytomx Thera 151 OYSTER POINT BLVD.SUITE 400 SOUTH SAN FRANCISCO CA 94080 USA

P: 650-515-3185 F: 650-351-0353

Description:

CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 270,184
Shares Outstanding, K 45,409
Annual Sales, $ 59,500 K
Annual Net Income, $ -84,600 K
Last Quarter Sales, $ 9,010 K
Last Quarter Net Income, $ -28,960 K
60-Month Beta 0.64
% of Insider Shareholders 6.30%
% of Institutional Shareholders 78.33%
Float, K 42,548
% Float 93.70%

Growth:

1-Year Return -62.73%
3-Year Return -52.30%
5-Year Return 0.00%
5-Year Revenue Growth 6,661.36%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/07/19
Earnings Per Share ttm -2.20
EPS Growth vs. Prev Qtr 18.75%
EPS Growth vs. Prev Year 1.89%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

CTMX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -11.74
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -83.69
Return-on-Assets (Before Tax) -22.73
Profit Margin % -142.18
Net Margin % N/A
Debt/Equity 0.26
Price/Sales 4.69
Price/Cash Flow N/A
Price/Book 2.75
Book Value/Share 2.24
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar